FDA Orange Book

Generic for Actoplus Met

Actoplus Met contains pioglitazone and metformin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Actoplus Met is pioglitazone and metformin. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Actoplus Met and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Actoplus Met products in the Orange Book

Actoplus Met products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oral500MG;EQ 15MG BASEDiscontinuedNone4AB
tablet, oral850MG;EQ 15MG BASEMarketed (Rx)AB4AB

NDA 021842, held by TAKEDA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic pioglitazone and metformin

Approved generic versions of Actoplus Met
CompanyANDATE codeApprovedStrengths
AUROBINDO PHARMA LTD200823AB (A-rated, therapeutically equivalent)February 13, 2013500MG;EQ 15MG BASE, 850MG;EQ 15MG BASE
TORRENT PHARMACEUTICALS LTD202001AB (A-rated, therapeutically equivalent)February 13, 2013500MG;EQ 15MG BASE, 850MG;EQ 15MG BASE
TEVA PHARMACEUTICALS USA091155AB (A-rated, therapeutically equivalent)March 10, 2014500MG;EQ 15MG BASE, 850MG;EQ 15MG BASE
MACLEODS PHARMACEUTICALS LTD204802AB (A-rated, therapeutically equivalent)November 5, 2015500MG;EQ 15MG BASE, 850MG;EQ 15MG BASE

Actoplus Met patents

Patents listed for Actoplus Met
PatentExpiresCoversUse codeNDA
9101660January 22, 2027Drug productNone021842
9320714February 3, 2029Drug productNone021842

Actoplus Met NDC codes

Questions

Is there a generic for Actoplus Met?

Yes. The generic name for Actoplus Met is pioglitazone and metformin. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Actoplus Met?

The active ingredient in Actoplus Met is pioglitazone and metformin, per the FDA Orange Book.

When does the Actoplus Met patent expire?

The last patent listed for Actoplus Met in the Orange Book expires February 3, 2029. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Actoplus Met and Pioglitazone and Metformin

Try it on your own data today.

Free to start. Most teams are using it the same day.